Evidence map›Paper›PMID 23840857›Full record

ArticlePloS one2013

Functional complementation of a model target to study Vpu sensitivity.

Sanath Kumar Janaka, Jared Faurot, Marc C Johnson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sanath Kumar JanakaDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, Missouri, United States of America.
Jared Faurot
Marc C Johnson
University of Missouri · US

Funding

Elucidation of HIV Env acquisition strategiesR01AI073098 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI JOHNSON, MARC C · 2008 to 2012
$1.5M
Mechanistic studies of an unexpected HIV-1 Vpu functionR21AI087448 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI JOHNSON, MARC C · 2010 to 2011
$415k
NIAID NIH HHS R01 AI073098NIAID NIH HHS R01 AI73098NIAID NIH HHS R21 AI087448
6 · The paper itself

Abstract

HIV-1 forms infectious particles with Murine Leukemia virus (MLV) Env, but not with the closely related Gibbon ape Leukemia Virus (GaLV) Env. We have determined that the incompatibility between HIV-1 and GaLV Env is primarily caused by the HIV-1 accessory protein Vpu, which prevents GaLV Env from being incorporated into particles. We have characterized the 'Vpu sensitivity sequence' in the cytoplasmic tail domain (CTD) of GaLV Env using a chimeric MLV Env with the GaLV Env CTD (MLV/GaLV Env). Vpu sensitivity is dependent on an alpha helix with a positively charged face containing at least one Lysine. In the present study, we utilized functional complementation to address whether all the three helices in the CTD of an Env trimer have to contain the Vpu sensitivity motif for the trimer to be modulated by Vpu. Taking advantage of the functional complementation of the binding defective (D84K) and fusion defective (L493V) MLV and MLV/GaLV Env mutants, we were able to assay the activity of mixed trimers containing both MLV and GaLV CTDs. Mixed trimers containing both MLV and GaLV CTDs were functionally active and remained sensitive to Vpu. However, trimers containing an Env with the GaLV CTD and an Env with no CTD remained functional but were resistant to Vpu. Together these data suggest that the presence of at least one GaLV CTD is sufficient to make an Env trimer sensitive to Vpu, but only if it is part of a trimeric CTD complex.

Indexed as

AnimalsCell LineCytoplasmGene Products, envHEK293 CellsHIV-1HumansLeukemia Virus, Gibbon ApeLeukemia Virus, MurineMiceMutationProtein Structure, TertiaryViral Envelope ProteinsGene Products, envViral Envelope Proteins

Identifiers

PMID23840857
PMCPMC3695915
OpenAlexW1971897626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.